ATAI Life Sciences NV (NAS:ATAI)
$ 1.35 0.17 (14.41%) Market Cap: 226.53 Mil Enterprise Value: 129.29 Mil PE Ratio: 0 PB Ratio: 1.18 GF Score: 44/100

Q3 2022 ATAI Life Sciences NV Earnings Presentation Transcript

Nov 10, 2022 / 01:30PM GMT
Release Date Price: $2.93 (+7.72%)
Stephen B. Bardin
Atai Life Sciences N.V. - MD & CFO

Presentation
Nov 10, 2022 / 01:30PM GMT

=====================
Corporate Participants
=====================
* Florian Brand
Atai Life Sciences N.V. - Co-founder & CEO
* Srinivas G. Rao
Atai Life Sciences N.V. - Co-Founder & Chief Scientific Officer
* Stephen B. Bardin
Atai Life Sciences N.V. - MD & CFO

=====================
Conference Call Participants
=====================
* Lin Tsai
Jefferies LLC, Research Division - Equity Analyst
* Ritu Subhalaksmi Baral
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst

=====================
-

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot